Description Module

Description Module

The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.

Description Module path is as follows:

Study -> Protocol Section -> Description Module

Description Module


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2025-12-24 @ 6:36 PM
NCT ID: NCT06815757
Brief Summary: Dystonia is a movement disorder involving involuntary, sustained, or intermittent muscle contractions that cause abnormal postures and repetitive movements, worsened by voluntary actions or stress. It is linked to dysfunctions in the basal ganglia, thalamus, and cerebellum, affecting sensorimotor integration. In children, dystonia often coexists with other disorders like spasticity in cerebral palsy, complicating diagnosis and treatment. Dystonia can be genetic, caused by mutations, or acquired, associated with conditions such as cerebral palsy, perinatal brain injury, and metabolic disorders. A key complication of pediatric dystonia is swallowing dysfunction (oropharyngeal dysphagia), which impairs airway protection and nutrition, increasing the risk of aspiration pneumonia. Studies have shown swallowing impairments across all phases (oral, pharyngeal, and esophageal) in children with dyskinetic cerebral palsy. However, due to pathophysiological differences between dystonia and cerebral palsy, generalizing findings may lead to inaccuracies. Each dystonia subtype presents unique challenges that affect swallowing function, emphasizing the need for condition-specific assessment and interventions. This study aims to fill the research gap by exploring the clinical features of swallowing dysfunction in children with dystonia, providing insights to improve care and outcomes.
Detailed Description: Dystonia is a neurological disorder characterized by involuntary muscle contractions that cause abnormal postures and repetitive movements. These symptoms are often exacerbated by voluntary actions or stress. The condition is linked to dysfunctions in brain regions responsible for motor control, including the basal ganglia, thalamus, and cerebellum, which disrupt sensorimotor integration. In children, dystonia frequently coexists with other neurological disorders, particularly cerebral palsy, making diagnosis and management more complex. The etiology of dystonia is both genetic and acquired. Genetic forms, though rare, are associated with progressive motor impairments due to mutations in genes. Acquired dystonias are more common and are linked to risk factors like perinatal brain injury, cerebral palsy, and metabolic disorders. Children with dyskinetic cerebral palsy are particularly vulnerable, as their condition shares clinical features with dystonia. A key complication in pediatric dystonia is oropharyngeal dysphagia, a disorder affecting the ability to swallow. Swallowing requires precise neuromuscular coordination across oral, pharyngeal, and esophageal phases. Disruptions in this process can lead to malnutrition, dehydration, and aspiration pneumonia. Studies on dyskinetic cerebral palsy have highlighted impairments in all phases of swallowing, but due to differences in muscle activation and positioning risks, these findings may not fully apply to children with dystonia. Each dystonia subtype presents unique clinical challenges. For instance, children with spastic cerebral palsy face high risks of aspiration in a supine position, while children with dystonia may tolerate this position better. Therefore, individualized assessments are essential to ensure accurate diagnosis and treatment. This study aims to explore the clinical characteristics of swallowing dysfunction in children with dystonia. By investigating how various causes influence its presentation, we seek to develop better diagnostic tools and treatment strategies to improve patient care and quality of life.
Study: NCT06815757
Study Brief:
Protocol Section: NCT06815757